Using a murine model of haemophilia A, we previously demonstrated in a proof‐of‐principle study that oral delivery of FVIII domains bioencapsulated in frozen leaf cells of transplastomic tobacco suppresses inhibitor formation. The gene discussed is F8; the disease is hemophilia A.